ReviewImmunoTargets and therapy2021

Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies.

Surojit Karmakar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.